None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are scheduled to undergo elective surgery 2. Patients of the American Society for the Classification of Physical Levels (ASA PS) 1-3 3. Patients aged 19 to 70 4. Patients voluntarily agreed to participate in this clinical trial in writing
Exclusion criteria
Exclusion criteria: 1. Patient with any contraindication to regional anesthesia. 2. Pregnant women 3. Patient with central nervous system acting medication 4. Patient with severe pain now 5. Patient with apparent liver disease or kidney disease 6. Patients with diseases including cardiovascular, respiratory, and nervous system 6.1 Patients with ECG abnormality and amiodarone in use 6.2 bradycardia (less than 50 heartbeats) 7. High spianl block of T4 or higher or conversion to general anesthesia 8. Patients deemed unfit for other studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of dexmedetomidine required to be BIS 70 between NHD and HD Group | — |
Secondary
| Measure | Time frame |
|---|---|
| Rescue midazolam requirement;Incidence of paradoxical rexcitement response;Incidence of side effects associated with dexmedetomidine or midazolam | — |
Countries
Korea, Republic of
Contacts
Chonnam National University Hospital